Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents |
Type de publication | Journal Article |
Year of Publication | 2015 |
Auteurs | Bertrand B, Citta A, Franken IL, Picquet M, Folda A, Scalcon V, Rigobello MPia, Le Gendre P, Casini A, Bodio E |
Journal | JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY |
Volume | 20 |
Pagination | 1005-1020 |
Date Published | SEP |
Type of Article | Article |
ISSN | 0949-8257 |
Mots-clés | Anticancer drug, Bimetallic complex, Gold complex, N-heterocyclic carbene, Thioredoxin reductase |
Résumé | While N-heterocyclic carbenes (NHC) are ubiquitous ligands in catalysis for organic or industrial syntheses, their potential to form transition metal complexes for medicinal applications has still to be exploited. Within this frame, we synthesized new homo- and heterobimetallic complexes based on the Au(I)-NHC scaffold. The compounds were synthesized via a microwave-assisted method developed in our laboratories using Au(I)-NHC complexes carrying a pentafluorophenol ester moiety and another Au(I) phosphane complex or a bipyridine ligand bearing a pendant amine function. Thus, we developed two different methods to prepare homo- and heterobimetallic complexes (Au(I)/Au(I) or Au(I)/Cu(II), Au(I)/Ru(II), respectively). All the compounds were fully characterized by several spectroscopic techniques including far infrared, and were tested for their antiproliferative effects in a series of human cancer cells. They showed moderate anticancer properties. Their toxic effects were also studied ex vivo using the precision-cut tissue slices (PCTS) technique and initial results concerning their reactivity with the seleno-enzyme thioredoxin reductase were obtained. |
DOI | 10.1007/s00775-015-1283-1 |